Search results
How 1301B7 Could Contribute To Advanced Vaccine Development
Forbes· 16 hours agoIn the ongoing Omicron era, a new COVID-19 antibody could renew optimism for urgently required...
House Republicans’ Attempts to Attack Fauci Go Wildly Off Rails
The New Republic via Yahoo News· 4 days ago“No—I’m on the record, and I want to make sure that this is clear: that I developed a monoclonal ...
Flu Breakthrough: Vanderbilt Scientists Discover Powerful New Weapon
SciTechDaily· 2 days agoVanderbilt University researchers have identified potent monoclonal antibodies against influenza B, showcasing a promising avenue for treatment and preventative strategies ...
Fauci Testimony Turns Chaotic: 'Most Insane Hearing I've Attended'
Rolling Stone· 4 days agoAnthony Fauci over his involvement in the response to the Covid-19 pandemic. Fauci was summoned...
High Confidence AD Drug Donanemab Will Get FDA Panel Nod
Medscape· 4 days agoThe Peripheral and Central Nervous System Drugs Advisory Committee of the US Food and Drug...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 1 day agoThe RSV market has altered substantially in recent years owing to the emergence of novel vaccines...
The Push to Get More People Into Long COVID Studies
Medscape· 4 days agoWhen Ezra Spier was diagnosed with long COVID in late 2022, his main symptom, postexertional malaise, caused fatigue so severe that it forced him to quit...
Fauci faces skeptical GOP to bat back COVID-19 accusations - Roll Call
CQ Politics· 4 days agoLongtime government scientist Anthony Fauci pushed back against Republican accusations tying him to...
Anti-CD20 HGG Linked to Serious Infection Risk in MS
Medscape· 16 hours agoHypogammaglobulinemia is a known risk linked to B-cell–depleting therapies, but a real-world study has specified the risk and risk factors in multiple...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 4 days agoGHENT, Belgium, June 04, 2024 (GLOBE NEWSWIRE) -- ExeVir Bio, a biotech company developing robust heavy chain-only antibody therapies for broad protection against infectious ...